Wen-Jun Zhang1, Zheng-Ming Zhu2. 1. The Second Affiliated Hospital, Nanchang University, Nanchang, 343000, Jiangxi, China. 2. The Second Affiliated Hospital, Nanchang University, Nanchang, 343000, Jiangxi, China. zzm8654@163.com.
Abstract
OBJECTIVES: Meta-analysis was used to determine the association between rs3751143 polymorphism of P2RX7 gene and the risk of chronic lymphocytic leukemia (CLL). METHODS: Search for published articles about the association between the rs3751143 and CLL in PubMed, MEDINE, Web of Science, and Embase databases, with a calculated odds ratio of (OR) and 95% confidence interval (95%CI). RESULTS: A total of 1184 cases and 1725 controls in 8 studies were pooled together for evaluation of the overall association between rs3751143 and risk of CLL. Allele model (A vs C, p = 0.16, OR = 0.85, 95%CI = 0.71-1.17), homozygous model (AA vs CC, p = 0.07; OR = 0.78, 95%CI = 0.84-1.08), and heterozygous model (AC vs CC, p = 0.76; OR = 0.85; 95%CI = 0.68-0.79) did not show decreased risk of developing CLL. Similarly, dominant model (AA + AC vs. CC: p = 0.58; OR = 1.10, 95%CI = 0.69-1.75), and recessive model (AA vs AC + CC, p = 0.21, OR = 1.18, 95%CI = 0.70-1.99) failed to show decreased risk of developing CLL. However, in familial, heterozygous model (AC vs. CC: p = 0.0006, OR = 0.64, 95%CI = 0.67-1.50) and recessive model (AA vs. AC + CC: p = 0.0017; OR = 1.02, 95%CI = 0.73-2.35) indicated the association between the inheritance of rs3751143 and the risk of developing CLL. In the overall survival prognosis, no significant association between rs3751143 and CLL was detected with relatively high heterogeneity. CONCLUSIONS: Our pooled data indicates that there is a correlation between the inheritance of rs3751143 and the risk of CLL in familial.
OBJECTIVES: Meta-analysis was used to determine the association between rs3751143 polymorphism of P2RX7 gene and the risk of chronic lymphocytic leukemia (CLL). METHODS: Search for published articles about the association between the rs3751143 and CLL in PubMed, MEDINE, Web of Science, and Embase databases, with a calculated odds ratio of (OR) and 95% confidence interval (95%CI). RESULTS: A total of 1184 cases and 1725 controls in 8 studies were pooled together for evaluation of the overall association between rs3751143 and risk of CLL. Allele model (A vs C, p = 0.16, OR = 0.85, 95%CI = 0.71-1.17), homozygous model (AA vs CC, p = 0.07; OR = 0.78, 95%CI = 0.84-1.08), and heterozygous model (AC vs CC, p = 0.76; OR = 0.85; 95%CI = 0.68-0.79) did not show decreased risk of developing CLL. Similarly, dominant model (AA + AC vs. CC: p = 0.58; OR = 1.10, 95%CI = 0.69-1.75), and recessive model (AA vs AC + CC, p = 0.21, OR = 1.18, 95%CI = 0.70-1.99) failed to show decreased risk of developing CLL. However, in familial, heterozygous model (AC vs. CC: p = 0.0006, OR = 0.64, 95%CI = 0.67-1.50) and recessive model (AA vs. AC + CC: p = 0.0017; OR = 1.02, 95%CI = 0.73-2.35) indicated the association between the inheritance of rs3751143 and the risk of developing CLL. In the overall survival prognosis, no significant association between rs3751143 and CLL was detected with relatively high heterogeneity. CONCLUSIONS: Our pooled data indicates that there is a correlation between the inheritance of rs3751143 and the risk of CLL in familial.
Authors: Lan-Phuong Dao-Ung; Stephen J Fuller; Ronald Sluyter; Kristen K SkarRatt; Ulf Thunberg; Gerard Tobin; Karen Byth; Maria Ban; Richard Rosenquist; Graeme J Stewart; James S Wiley Journal: Br J Haematol Date: 2004-06 Impact factor: 6.998
Authors: Dalemari Crowther-Swanepoel; Mahmoud Mansouri; Anna Enjuanes; Ana Vega; Karin E Smedby; Clara Ruiz-Ponte; Jesper Jurlander; Gunnar Juliusson; Emilio Montserrat; Daniel Catovsky; Elias Campo; Angel Carracedo; Richard Rosenquist; Richard S Houlston Journal: Br J Haematol Date: 2010-06-10 Impact factor: 6.998
Authors: B J Gu; W Zhang; R A Worthington; R Sluyter; P Dao-Ung; S Petrou; J A Barden; J S Wiley Journal: J Biol Chem Date: 2001-01-09 Impact factor: 5.157
Authors: James S Wiley; L Phuong Dao-Ung; Ben J Gu; Ronald Sluyter; Anne N Shemon; Changping Li; John Taper; John Gallo; Arumugam Manoharan Journal: Lancet Date: 2002-03-30 Impact factor: 79.321
Authors: L Y Zhang; R E Ibbotson; J A Orchard; A C Gardiner; R V Seear; A J Chase; D G Oscier; N C P Cross Journal: Leukemia Date: 2003-11 Impact factor: 11.528
Authors: Natasha Monte; Karla B C C Pantoja; Juliana C G Rodrigues; Darlen C de Carvalho; Tereza C B Azevedo; Esdras E B Pereira; Paulo P de Assumpção; Sidney E B Dos Santos; Marianne R Fernandes; Ney P C Dos Santos Journal: Mol Genet Genomic Med Date: 2021-05-29 Impact factor: 2.183